Paul Romness
Förmögenhet: 5 M $ per 2026-05-31
Förmögenhet: 5 M $ per 2026-05-31
Paul A. Romness is the founder of OS Therapies, Inc. since 2018, holding the title of Chairman, President & Chief Executive Officer.
Former positions include Director-State Government Affairs at Amgen, Inc. from 2005 to 2008, Vice President-Government Affairs & Public Policy at Boehringer Ingelheim GmbH from 2008 to 2014, and Principal at PR Strategies from 2005 to 2008.
Education includes an undergraduate degree from American University and a graduate degree from Milken Institute School of Public Health.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-22 | 2 473 000 ( 5,55 % ) | 5 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| OS THERAPIES INCORPORATED | Verkställande Direktör | 2018-04-12 |
| Företag | Position | Slut |
|---|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Generell Rådgivare | 2014-01-01 |
| AMGEN INC. | Generell Rådgivare | 2008-03-01 |
PR Strategies | Företagsledare/Principal | 2008-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Milken Institute School of Public Health
Milken Institute School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OS Therapies, Inc.
OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
PR Strategies |
Välj din utgåva
All finansiell information anpassad till den nationella nivån